A PROPOSAL TO USE CA-125 TO EVALUATE ACTIVITY OF NEW ANTINEOPLASTIC AGENTS IN OVARIAN-CANCER

被引：8

作者：

MARKMAN, M ^{[1
]}

机构：

[1] CLEVELAND CLIN FDN,DEPT HEMATOL MED ONCOL,CLEVELAND,OH 44195

来源：

GYNECOLOGIC ONCOLOGY | 1993年 / 51卷 / 03期

关键词：

D O I：

10.1006/gyno.1993.1292

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：297 / 298

页数：2

共 9 条

[1] CA-125 SURVEILLANCE AND 2ND-LOOK LAPAROTOMY IN OVARIAN-CARCINOMA [J].

ATACK, DB ;

NISKER, JA ;

ALLEN, HH ;

TUSTANOFF, ER ;

LEVIN, L .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 154 (02) :287-289

[2] CA125 MEASUREMENT IN EPITHELIAL OVARIAN-CANCER - A 10-YEAR ANNIVERSARY OF CLINICAL INVESTIGATION [J].

BERKOWITZ, RS .

GYNECOLOGIC ONCOLOGY, 1993, 49 (01) :1-2

[3] SURAMIN, AN ACTIVE-DRUG FOR PROSTATE-CANCER - INTERIM OBSERVATIONS IN A PHASE-I TRIAL [J].

EISENBERGER, MA ;

REYNO, LM ;

JODRELL, DI ;

SINIBALDI, VJ ;

TKACZUK, KH ;

SRIDHARA, R ;

ZUHOWSKI, EG ;

LOWITT, MH ;

JACOBS, SC ;

EGORIN, MJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (08) :611-621

[4] SERUM CA-125 LEVEL ALLOWS EARLY IDENTIFICATION OF NONRESPONDERS DURING INDUCTION CHEMOTHERAPY [J].

MAKAR, AP ;

KRISTENSEN, GB ;

BORMER, OP ;

TROPE, CG .

GYNECOLOGIC ONCOLOGY, 1993, 49 (01) :73-79

[5] IS SERUM CA-125 AT THE TIME OF RELAPSE A PROGNOSTIC INDICATOR FOR FURTHER SURVIVAL PROGNOSIS IN PATIENTS WITH OVARIAN-CANCER [J].

MAKAR, AP ;

KRISTENSEN, GB ;

BORMER, OP ;

TROPE, CG .

GYNECOLOGIC ONCOLOGY, 1993, 49 (01) :3-7

[6] PROGNOSTIC VALUE OF CA-125 IN ADVANCED OVARIAN-CANCER [J].

MOGENSEN, O .

GYNECOLOGIC ONCOLOGY, 1992, 44 (03) :207-212

[7]

MORGAN R, 1993, P AM SOC CLIN ONCOL, V12, P274

[8]

Rosenberg SA., CANC PRINCIPLES PRAC, Ved, P895

[9]

THIBAULT A, 1993, P AM ASSOC CANC RES, V34, pA1143

← 1 →